Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
Article first published online: 12 JUL 2013
© 2013 Royal College of Obstetricians and Gynaecologists
The Obstetrician & Gynaecologist
Volume 15, Issue 3, pages 171–176, July 2013
How to Cite
Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism The Obstetrician & Gynaecologist 2013.15:171–6., , , .
- Issue published online: 12 JUL 2013
- Article first published online: 12 JUL 2013
- Manuscript Accepted: 2 APR 2012
- Manuscript Revised: 27 JAN 2012
- Manuscript Received: 19 APR 2011
- polycystic ovary syndrome
- The presence of clinical or biochemical evidence of hyperandrogenism is a defining feature of polycystic ovary syndrome (PCOS).
- As the criteria for diagnosing PCOS becomes more inclusive, there is an increased risk of misdiagnosing women with other causes of hyperandrogenism.
- Biochemical testing for serum testosterone concentrations in women has important limitations.
- Patients with concerning features should be investigated for other causes of hyperandrogenism.
- To review the different criteria for diagnosing PCOS and the repercussions for disease prevalence.
- To learn about the differential diagnosis of hyperandrogenism.
- To learn about the limitations of biochemical testing for testosterone in women.
- Hyperandrogenism causing hirsutism and virilisation can have significant effects on physical and psychological wellbeing.
- Misdiagnosis can delay appropriate treatment and may affect future fertility.